Tectonic Therapeutic, Inc. — Director's Dealing 2022

Jun 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2022-06-08

Reporting Person: PAIGE CHRISTOPHER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-08	Stock Option (Right to Buy)	$1.06	A	17478	Acquired	2032-06-07	Common Stock (17478)	Direct
2022-06-08	Stock Option (Right to Buy)	$1.06	A	17478	Acquired	2032-06-07	Common Stock (17478)	Direct

Footnotes

F1: The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.